Rocio Suarez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Interleukin-11 promotes lung adenocarcinoma tumourigenesis and immune evasion.
Journal: Clinical and translational medicine
Published: December 04, 2024
Telomere-based risk models for the early diagnosis of lung cancer.
Journal: Heliyon
Published: June 12, 2023
Air change rates and infection risk in school environments: Monitoring naturally ventilated classrooms in a northern Italian urban context.
Journal: Heliyon
Published: May 22, 2023
Ventilation strategies to reduce airborne transmission of viruses in classrooms: A systematic review of scientific literature.
Journal: Building and environment
Published: March 30, 2022
FGFR4 increases EGFR oncogenic signaling in lung adenocarcinoma, and their combined inhibition is highly effective.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 29, 2018
FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 06, 2018
MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 16, 2018
Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer.
Journal: Oncotarget
Published: September 16, 2015
MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD.
Journal: The European respiratory journal
Published: April 19, 2014
Last Updated: 09/26/2026